| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/11/2006 | US7074386 Contacting a microporous material with a hydrostatic fluid having at least one specified material carried therein, under pressure which structurally distorts the lattice sufficiently to permit entry of the at least one specified material |
| 07/06/2006 | WO2006071138A1 Tritium-traced saxitoxin dihydrochloride and method for the production thereof |
| 07/06/2006 | WO2006012355A3 Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same |
| 07/06/2006 | US20060149159 Method for measuring pancreatic metabolism |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147428 Allogeneic and xenogeneic transplantation |
| 07/06/2006 | US20060147375 Antibodies and related molecules that bind to PSCA proteins |
| 07/06/2006 | US20060147374 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | US20060147373 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | US20060147372 DNA encoding MCK-10, a novel receptor tyrosine kinase |
| 07/06/2006 | US20060147371 Sustained delivery of chemotherapeutic agent at high concentration without damaging normal cells beyond repair |
| 07/06/2006 | DE102004022461B4 Metallkomplexe auf der Basis von Tetrathiol-Liganden und deren Anwendung in der nuklearmedizinischen Diagnostik und Endoradionuklidtherapie sowie Verfahren zur Herstellung der Metallkomplexe Metal complexes based on Tetrathiol ligands and their use in nuclear medical diagnosis and endoradionuclide therapy and methods for preparing the metal complexes |
| 07/05/2006 | EP1675626A2 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 07/05/2006 | EP1675625A1 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/05/2006 | EP1107979B1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | CN1798580A Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2319544C Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 06/29/2006 | WO2006068015A1 Method of producing potassium [18f] fluoride and quaternary ammonium [18f] fluoride and method of producing radioactive fluorine-labeled organic compound by using the same |
| 06/29/2006 | WO2006067376A2 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 06/29/2006 | WO2006067366A1 Stabilisation of radiopharmaceutical precursors |
| 06/29/2006 | WO2006067094A1 Method for isolating neural cells using tenascin-r compounds |
| 06/29/2006 | WO2006037124A3 Container with constrained quality maintenance agent |
| 06/29/2006 | WO2005107730A3 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/29/2006 | WO2005084168A3 MINIATURIZED 62Zn/62Cu GENERATOR FOR HIGH CONCENTRATION CLINICAL DELIVERY OF 62Cu KIT FORMULATION FOR THE FACILE PREPARATION OF RADIOLABELED Cu-BIS(THIOSEMICARBAZONE) COMPOUNDS |
| 06/29/2006 | WO2005051315A3 On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060141535 Hyaluronan receptor for endocytosis |
| 06/29/2006 | US20060140903 Diagnoses and treatment of disorders using an alternative glucose pathway |
| 06/29/2006 | US20060140859 Imaging agents for early detection and monitoring of cardiovascular plaque |
| 06/29/2006 | US20060140858 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/29/2006 | US20060140857 Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method |
| 06/29/2006 | US20060140856 Skeletal-targeted radiation to treat bone-associated pathologies |
| 06/29/2006 | DE19928911B4 Verfahren zur Herstellung von 3-0-Methyl-6-[18F]Fluor-DOPA, (3-0-Methyl-6-[18F]Fluor-L-4-hydroxyphenylalanin, 3-(2-[18F]Fluor-4-hydroxy-5-methoxy-phenyl)-2-amino-propansäure) Process for the preparation of 3-0-methyl-6- [18F] fluoro-DOPA, (3-0-methyl-6- [18F] fluoro-L-4-hydroxyphenylalanine, 3- (2- [18F] fluoro-4 -hydroxy-5-methoxy-phenyl) -2-amino-propanoic acid) |
| 06/29/2006 | CA2817636A1 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 06/29/2006 | CA2592249A1 Binding proteins specific for human matriptase |
| 06/29/2006 | CA2589136A1 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 06/29/2006 | CA2587839A1 Stabilisation of radiopharmaceutical precursors |
| 06/28/2006 | EP1673492A2 Radium target and method for producing it |
| 06/28/2006 | EP1673110A2 Radiolabeled anilinoquinazolines and their use in radioimaging and radiotherapy |
| 06/28/2006 | EP1673108A2 Methods and compositions for ultrasound imaging of apoptosis |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | EP1140212B1 The use of radium-223 to target calcified tissues for pain palliation and therapy of bone cancer |
| 06/28/2006 | EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 06/28/2006 | CN1795198A Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 06/28/2006 | CN1795015A Optically pure and enriched isomers of chelating ligands and contrast agents |
| 06/28/2006 | CN1261416C Perfuoroalkylamide, prodn. and use in diagnostics thereof |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067508 Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 06/27/2006 | US7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin |
| 06/27/2006 | US7067276 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067111 Antitumor agents; chelate compounds |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/22/2006 | WO2006066104A2 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/22/2006 | WO2006064451A2 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 06/22/2006 | WO2006064227A1 Magnetic resonance contrast media |
| 06/22/2006 | WO2006064175A1 STABILISED 99mTC COMPOSITIONS |
| 06/22/2006 | WO2006063418A2 Nanostructure radioactif |
| 06/22/2006 | WO2006038184A3 Compounds, kits and methods for use in medical imaging |
| 06/22/2006 | WO2006026380A3 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/22/2006 | WO2005094897A3 Pegylated ion channel modulating compounds |
| 06/22/2006 | US20060135842 Radiotherapy |
| 06/22/2006 | US20060135404 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/22/2006 | US20060133995 use of a ligand contained in the selected contrast agent as a pharmaceutical active agent for treating the patient, as a carrier for a pharmaceutical active agent, as a ligand of a further contrast agent and/or as an "in vitro" diagnostic reagent |
| 06/22/2006 | US20060133994 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/21/2006 | EP1670519A2 Radiolabeled thymidine solid-phase extraction purification method |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | CN1260234C Diphosphonic acid derivative, 99 mTc labelled diphos phonic acid derivative and its application |
| 06/20/2006 | US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition |
| 06/20/2006 | US7063658 System having a carrier substrate and a Ti/P or A1/P coating |
| 06/15/2006 | WO2005120589A3 Contrast agent comprising alginate and an isotope or paramagnetic ion |
| 06/15/2006 | WO2005089815A3 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 06/15/2006 | WO2005084715A3 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 06/15/2006 | US20060127311 Radiation dosimetry and blocking antibodies and methods and uses therefor in the treatment of cancer |
| 06/15/2006 | US20060127310 Amplification of biotin-mediated targeting |
| 06/15/2006 | US20060127309 Imaging agents |
| 06/15/2006 | US20060127308 Method to improve the efficacy of therapeutic radiolabeled drugs |
| 06/15/2006 | US20060127307 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 06/15/2006 | US20060127306 Radioactively labelled amino acid analogues, their preparation and use |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |
| 06/14/2006 | EP1667794A2 System and method for synthesis of molecular imaging probes including fdg |
| 06/14/2006 | EP1438076B1 Radiopharmaceutical agent for the treatment of early stage cancer |
| 06/14/2006 | EP1404353A4 Methods of using a hyaluronan receptor |
| 06/14/2006 | EP1301216B1 CARRIER-FREE 103 Pd BRACHYTHERAPY SEEDS |
| 06/14/2006 | CN1786009A Application of 99TcmN (CPEDTC)2 compounding agent in tumour imaging field |
| 06/14/2006 | CN1259418C Coding recombinant adenoviruses for iodine specific transport protein |
| 06/13/2006 | USRE39132 Thiazoline acid derivatives |
| 06/13/2006 | US7060724 Water soluble paclitaxel derivatives |
| 06/13/2006 | US7060689 Methods and compositions for delivery and retention of active agents to lymph nodes |
| 06/13/2006 | US7060272 Death domain containing receptor-4 agonist antibodies and methods |